Long-term efficacy and safety of perampanel monotherapy in patients with newly diagnosed or currently untreated recurrent focal-onset seizures: Results from the open-label extension phase of FREEDOM (Study 342)

FREEDOM (Study 342; NCT03201900) assessed the long-term treatment effect of perampanel monotherapy in adolescent and adult patients (12–74 years of age) with untreated focal-onset seizures (FOS), with or without focal to bilateral tonic-clonic seizures (FBTCS). In the Core Study, after a 4-week Pret...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Epilepsy research 2025-02, Vol.210, p.107494, Article 107494
Hauptverfasser:	Yamamoto, Takamichi, Lim, Sung Chul, Ninomiya, Hirotomo, Kubota, Yuichi, Shin, Won Chul, Kim, Dong Wook, Shin, Dong Jin, Iida, Koji, Ochiai, Taku, Matsunaga, Risa, Hiramatsu, Hidetaka, Kim, Ji Hyun
Format:	Artikel
Sprache:	eng
Schlagworte:	Anti-seizure medication Focal-onset seizures Long-term monotherapy Perampanel Seizure freedom
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!